Glaucoma

There are 655 papers on glaucoma in aging research: 8 trials and 321 observational studies in people, 51 in animals, 7 in cells, 223 reviews. The newest story, Nov 8, 2026: “Ontario eye exam delisting linked to undetected eye disease”.

Disease

655 papers study it409 more mention it287 findings

MeSH

47 new papers in 30 daysSee all 1,064 papers on glaucoma

At a glance

Glaucoma is linked with frailty and dementia in human studies, and with falls and visual impairment in older adults. A longitudinal human study associates glaucoma with faster retinal ganglion cell loss. Human cohorts also link advanced cardiovascular-kidney-metabolic syndrome and higher triglyceride-glucose indices with higher glaucoma risk.

287 findings in 198 papers from 2016 to 2026, 50 of them since April 2026

“Individuals who self-identified as having preexisting glaucoma (odds ratio [OR] = 3.749, 95% confidence interval [CI] = 1.741-8.074, p = 0.0001)”
Manhattan Vision Screening and Follow-Up Study: (NYC-SIGHT)Tele-Retinal Image Findings and Importance of PhotographyTelemedicine journal and e-health : the official journal of the American Telemedicine Association2023doi:10.1089/tmj.2023.0134
  • Human trial8
  • Humans321
  • Animals51
  • Cells7
  • In silico37

Interventions

9

Nicotinamide

downin mice2−70% eyes had no detectable glaucomatous neurodegeneration

2 studies
  1. Nicotinamide protects against glaucoma in the DBA/2J mouse model of inherited glaucoma (~70% of eyes had no detectable glaucomatous neurodegeneration).

    “At the lowest dose tested, nicotinamide robustly protected from glaucoma (~70% of eyes had no detectable glaucomatous neurodegeneration).”

    Reviewin the DBA/2J mouse model of inherited glaucomaretinalowest dose tested

    Glaucoma as a Metabolic Optic Neuropathy: Making the Case for Nicotinamide Treatment in Glaucoma

    Journal of glaucoma

  2. Nicotinamide protects against glaucoma in mice.

    “Oral administration of the NAD+ precursor nicotinamide (vitamin B3), and/or gene therapy (driving expression of Nmnat1, a key NAD+-producing enzyme), was protective both prophylactically and as an intervention.”

    Animalsglaucoma-prone mice; prophylactic and interventional administration, alone and/or with Nmnat1 gene therapyeye

    Vitamin B₃ modulates mitochondrial vulnerability and prevents glaucoma in aged mice

    Science (New York, N.Y.)

More on Nicotinamide

Secondhand smoke

no changein humans1

1 study
  1. Secondhand smoke was not clearly linked with glaucoma in humans (Lifetime never-smokers).

    “Average macular GCIPL thickness (P=0.617) and glaucoma (P=0.170) were not significantly associated with SHS exposure.”

    HumansLifetime never-smokersn = 4,276

    Home and Workplace Secondhand Smoke and Retinal Nerve Fiber Layer Thinning in Never-Smokers: A Nationwide Population-Based Study

    American journal of ophthalmology

More on Secondhand smoke

Outdoor artificial light at night

no changein humans1

1 study
  1. Outdoor artificial light at night was not clearly linked with glaucoma in humans.

    “exhibiting no significant associations with glaucoma, diabetic retinopathy, or cataracts.”

    Humanseyen = 16,352

    Non-linear association between outdoor artificial light at night and visual impairment: a two-stage study integrating national CHARLS data and institutional clinical records

    Research SquarePreprint

More on Outdoor artificial light at night

Moderate-to-vigorous physical activity

no changein humans1

1 study
  1. Moderate-to-vigorous physical activity was not clearly linked with glaucoma in humans.

    “and no significant association for glaucoma.”

    Humansmedian follow-up of 6.2 yearsn = 77,644

    Accelerometer-Derived Moderate-to-Vigorous Physical Activity and the Risk of Four Common Vision-Threatening Ocular Diseases

    Translational vision science & technology

More on Moderate-to-vigorous physical activity

Magnesium acetyltaurate

downin reviews1

1 study
  1. Magnesium acetyltaurate decreases glaucoma in ocular diseases.

    “helped reduce glaucomatous changes, mitigated retinal damage caused by hyperglycemia in DR, and inhibited inflammation in AMD.”

    Reviewin ocular diseases

    Magnesium acetyltaurate and ocular neurodegenerative diseases: A review

    Indian Journal of Clinical and Experimental Ophthalmology

More on Magnesium acetyltaurate

Water intake

no changein humans1OR 1.16

1 study
  1. Water intake was not clearly linked with glaucoma in humans (OR: 1.16; 95% CI: 0.72-1.88).

    “Water intake had no effect on glaucoma (OR: 1.16; 95% CI: 0.72-1.88; P = 0.549).”

    Humans

    The protective role of water intake in age-related eye diseases: insights from a Mendelian randomization study

    Food & function

More on Water intake

Alcohol

no changein humans1

1 study
  1. Alcohol was not clearly linked with glaucoma in humans.

    “Alcohol consumption frequency and total alcohol intake were not associated with glaucoma.”

    Humansn = 30,097

    Alcohol Consumption, Genetic Risk, and Intraocular Pressure and Glaucoma: The Canadian Longitudinal Study on Aging

    Investigative ophthalmology & visual science

More on Alcohol

Vitamin E

downin reviews1

1 study
  1. Vitamin E protects against glaucoma in basic experimental studies.

    “that the process can be prevented or ameliorated by vitamin E”

    Reviewin basic experimental studies

    Reported evidence of vitamin E protection against cataract and glaucoma

    Free radical biology & medicine

More on Vitamin E

NMNAT1 gene therapy

downin mice1

1 study
  1. NMNAT1 gene therapy protects against glaucoma in mice.

    “gene therapy (driving expression of Nmnat1, a key NAD+-producing enzyme), was protective both prophylactically and as an intervention.”

    Animalsglaucoma-prone mice; prophylactic and interventional administration, alone and/or with nicotinamidedriving expression of Nmnat1eye

    Vitamin B₃ modulates mitochondrial vulnerability and prevents glaucoma in aged mice

    Science (New York, N.Y.)

More on NMNAT1 gene therapy

Effects

33

Oxygen consumption rate

downin human cells1downin humans1

2 studies
  1. Glaucoma decreases oxygen consumption rate in humans (relative to healthy individuals).

    “glaucoma patients exhibit a metabolic vulnerability, characterized by lower PBMC oxygen consumption rates and depleted systemic nicotinamide adenine dinucleotide levels relative to healthy individuals”

    Reviewrelative to healthy individuals

    Peripheral Blood Mononuclear Cell Oxygen Consumption and Systemic Bioenergetics in Glaucoma Management

    International journal of molecular sciences

  2. Glaucoma decreases oxygen consumption rate in human cells (cataract patients) (2.27±1.19 vs. 2.83±1.286 fmol/min/cell).

    “glaucoma patients had lower OCR than non-glaucoma patients (2.27±1.19 vs. 2.83±1.286 fmol/min/cell; p<0.05).”

    Cellscataract patientslens epithelial cellsn = 69

    Mitochondrial oxygen metabolism in primary human lens epithelial cells: Association with age, diabetes and glaucoma

    Free radical biology & medicine

More on Oxygen consumption rate

Gait speed

downin humans2

2 studies
  1. Glaucoma is linked with worse gait speed in humans (-0.11 (-0.16 to -0.05) m/s).

    “Individuals with glaucoma (-0.11 (-0.16 to -0.05) m/s), distance vision impairment (-0.02 (-0.03 to 0.00) m/s) or vision problem (-0.02 (-0.05 to 0.00) m/s) had decreased gait speed compared with the control group.”

    Humans

    Associations of vision impairment and eye diseases with frailty in community-dwelling older adults: a nationwide longitudinal study in China

    The British journal of ophthalmology

  2. Glaucoma is linked with worse gait speed in humans (glaucoma vs normal controls) (P < .05).

    “When walking without an obstacle on a 6 m path, there were significant differences between the 2 groups in gait speed, cadence, gait cycle, and stance time (P < .05).”

    Humansglaucoma vs normal controlsn = 30

    Gait characteristics during crossing over obstacle in patients with glaucoma using insole foot pressure

    Medicine

Ganglion cell soma density

downin humans1−32% /year

1 study
  1. Glaucoma is linked with lower ganglion cell soma density in humans within an arcuate defect (-31.6%/year).

    “By contrast, one glaucoma patient showed a loss rate within an arcuate defect over 100× greater (-31.6%/year; corresponding GCL thinning rate of -13%/year)”

    Humanswithin an arcuate defectretina2 to 3 years

    Cumulative Loss of Inner Retinal Neurons in Healthy and Glaucoma Subjects

    Investigative ophthalmology & visual science

More on Ganglion cell soma density

miR-145-5p

upin humans1

1 study
  1. Glaucoma is linked with higher miR-145-5p in humans (glaucomatous tissues).

    “Interestingly, miR-145-5p, miR-22-3p and miR-376a-3p showed up-regulation in TM of glaucomatous tissues.”

    Humansglaucomatous tissuestrabecular meshwork

    MicroRNA profiling of filtering and non-filtering regions of human trabecular meshwork: changes with ageing and in glaucoma

    Molecular biology reports

More on miR-145-5p

Calcium

upin silico1OR 1.044

1 study
  1. Glaucoma increases calcium in silico (Mendelian randomization) (OR = 1.044, 95% CI: 1.002-1.088).

    “glaucoma contributed to elevated calcium concentration (OR = 1.044, 95% CI: 1.002-1.088, p = 0.039) in blood and urine”

    In silicoMendelian randomization

    Unveiling Systemic Biomarkers and Metabolic Mechanisms in Glaucoma Progression from Multi-Omics Insights

    International journal of molecular sciences

More on Calcium

NAD+

downin humans1

1 study
  1. Glaucoma decreases NAD+ in humans (relative to healthy individuals).

    “lower PBMC oxygen consumption rates and depleted systemic nicotinamide adenine dinucleotide levels relative to healthy individuals”

    Reviewrelative to healthy individuals

    Peripheral Blood Mononuclear Cell Oxygen Consumption and Systemic Bioenergetics in Glaucoma Management

    International journal of molecular sciences

More on NAD+

Sustained inhibitory currents

downin mice1

1 study
  1. Glaucoma decreases sustained inhibitory currents in mice (glaucoma).

    “decreased magnitude of sustained inhibitory currents from delta subunit-containing GABA receptors”

    Animalsglaucomadorsolateral geniculate nucleus

    Compensatory responses to glaucoma pathology in the dorsolateral geniculate nucleus

    iScience

More on Sustained inhibitory currents

Intrinsic excitability

upin mice1

1 study
  1. Glaucoma increases intrinsic excitability in mice (glaucoma).

    “This was accompanied by increased intrinsic excitability”

    Animalsglaucomadorsolateral geniculate nucleus

    Compensatory responses to glaucoma pathology in the dorsolateral geniculate nucleus

    iScience

Extracellular NAMPT

no changein humans1

1 study
  1. Glaucoma was not clearly linked with extracellular NAMPT in humans.

    “eNAMPT levels showed no difference between glaucoma and controls, nor changes after supplementation.”

    Humansn = 90

    Circulating eNAMPT in Glaucoma: A Semi-Quantitative Plasma Analysis Before and After Nicotinamide Supplementation

    Translational vision science & technology

More on Extracellular NAMPT

Parkinson's disease

no changein humans1HR 1.145

1 study
  1. Glaucoma was not clearly linked with Parkinson's disease in humans (Glaucoma patients compared with sex- and age-matched controls) (Adjusted HR 1.145 (95% CI 0.975–1.345)).

    “Glaucoma was not significantly associated with an increased risk of PD, with an adjusted HR of 1.145 (95% CI = 0.975-1.345).”

    HumansGlaucoma patients compared with sex- and age-matched controls20-year follow-upn = 139,554

    Parkinson's disease incidence in glaucoma patients from israel: insights from a 20-year follow-up sample

    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie

More on Parkinson's disease

All 33

Upstream

10

Metabolic vulnerability index

no changein humans1HR 1

1 study
  1. Metabolic vulnerability index was not clearly linked with glaucoma in humans (HR = 1.00; 95% CI: 0.97-1.03).

    “no significant association was observed for glaucoma (HR = 1.00; 95% CI: 0.97-1.03)”

    Humansn = 206,311

    Metabolic vulnerability, genetic susceptibility, and incident age-related eye diseases: a prospective cohort study

    Frontiers in nutrition

More on Metabolic vulnerability index

Serum Klotho

no changein humans1

1 study
  1. Serum Klotho was not clearly linked with glaucoma in humans (bidirectional two-sample Mendelian randomization).

    “MR analyses found no evidence of a causal relationship between Klotho and glaucoma in either direction.”

    Humansbidirectional two-sample Mendelian randomizationserum

    Serum Klotho Levels and Major Age-Related Ocular Disorders: A Cross-Sectional and Genetic Association Study

    Translational vision science & technology

More on Serum Klotho

Clonal hematopoiesis of indeterminate potential

no changein humans1HR 1.08

1 study
  1. Clonal hematopoiesis of indeterminate potential was not clearly linked with glaucoma in humans (Free of the four eye diseases at baseline) (HR 1.08, 95% CI 0.99–1.17).

    “No significant association was found with glaucoma (HR, 1.08; 95% CI, 0.99-1.17).”

    HumansFree of the four eye diseases at baselineMedian follow-up of 13.1 years54.5% womensn = 436,469

    Clonal Hematopoiesis of Indeterminate Potential and Risk of Major Age-Related Eye Diseases

    medRxivPreprint

More on Clonal hematopoiesis of indeterminate potential

Chronic pain

no changein humans1

1 study
  1. Chronic pain was not clearly linked with glaucoma in humans (Chronic pain in one or two locations versus no chronic pain).

    “chronic pain in one or two locations did not show a significant association with glaucoma”

    HumansChronic pain in one or two locations versus no chronic pain

    Association Between Chronic Pain and Risk of Glaucoma: A Prospective Cohort Study

    Translational vision science & technology

More on Chronic pain

Intraocular pressure

mediatesin humans1

1 study
  1. Intraocular pressure is linked with glaucoma in humans (for caffeine's effect on glaucoma) (41 % (95 % CI −0·14, −0·01)).

    “Mediation analysis suggested that 41 % (95 % CI −0·14, −0·01) of caffeine’s effect on glaucoma was mediated by IOP.”

    Humansfor caffeine's effect on glaucoma

    Plasma caffeine level as a protective factor against age-related eye diseases: a two-sample Mendelian randomisation study

    The British journal of nutrition

More on Intraocular pressure

Uric acid

mediatesin humans1

1 study
  1. Uric acid is linked with glaucoma in humans (mediating PM2.5 and component associations with glaucoma) (12% to 15%).

    “Elevated serum UA levels played a mediated role in the association between PM2.5 mass and its five chemical components and glaucoma, with mediated proportions ranging from 12% to 15%.”

    Humansmediating PM2.5 and component associations with glaucoma

    Elevated serum uric acid levels mediate the associations of ambient PM2.5 and its components with glaucoma

    Chemosphere

More on Uric acid

Chronic kidney disease

no changein humans1HR 0.95

1 study
  1. Chronic kidney disease was not clearly linked with glaucoma in humans (Compared with individuals without kidney disease) (HR 0.95 (CI 0.85-1.06)).

    “with an elevated risk for all blocks of diagnoses except for glaucoma HR 0.95 (CI 0.85-1.06).”

    HumansCompared with individuals without kidney disease

    Eye diseases in chronic kidney disease: A nationwide longitudinal case-control study in Sweden

    Clinical & experimental ophthalmology

More on Chronic kidney disease

Prefrailty

no changein humans1OR 1.9

1 study
  1. Prefrailty was not clearly linked with glaucoma in humans (prefrail individuals vs nonfrail) (OR 1.90, 95% CI 0.99-3.64).

    “but not prefrail (OR = 1.90, 95% CI = 0.99-3.64, P = 0.052).”

    Humansprefrail individuals vs nonfrail

    Relationships between Frailty and the Risk of Glaucoma in Middle-aged and Older Adults

    Ophthalmology. Glaucoma

Myopia

no changein humans1

1 study
  1. Myopia was not clearly linked with glaucoma in humans.

    “A potential link was found between myopia and an increased risk of cataracts and macular degeneration, but not with glaucoma.”

    Humansn = 204,973

    Myopia and Nutrient Associations with Age-Related Eye Diseases in Korean Adults: A Cross-Sectional KNHANES Study

    Nutrients

More on Myopia

Oxidative stress and ROS signaling

mediatesin humans1

1 study
  1. Oxidative stress and ROS signaling mediates glaucoma in humans.

    “Age-related ocular pathologies including glaucoma, cataracts, and age-related macular degeneration are largely mediated by oxidative stress.”

    Review

    The Role of Oxidative Stress in the Aging Eye

    Life (Basel, Switzerland)

More on Oxidative stress and ROS signaling

Associations

180

Alzheimer's disease

upin humans5downin humans1HR 1.29–1.485

6 studies
  1. Glaucoma is linked with a higher risk of Alzheimer's disease in humans (HR = 1.485; 95% CI, 1.427-1.546).

    “glaucoma correlated with elevated 10-year risks for AD (HR = 1.485; 95% CI,1.427-1.546; P < .001)”

    Humans10 years

    Glaucoma and Neurodegenerative Disease Risk: A 10-Year Assessment of Real-World Global Data

    American journal of ophthalmology

  2. Glaucoma is associated with Alzheimer's disease in humans (Compared with individuals without glaucoma) (POAG: aHR 1.23 (95% CI 1.08–1.40); NTG: 1.49 (1.19–1.85); PACG: 1.35 (1.19–1.52); unspecified glaucoma: 1.36 (1.23–1.50)).

    “Irrespective of the type of glaucoma, individuals with glaucoma had a significantly higher risk of AD compared to those without glaucoma”

    HumansCompared with individuals without glaucoman = 202,000

    The association between antiglaucomatous agents and Alzheimer's disease

    Eye (London, England)

  3. Glaucoma is linked with a lower risk of Alzheimer's disease in humans (genetically predicted all-cause glaucoma) (OR = 0.96, 95% CI: 0.93-0.99).

    “The genetically predicted all-caused glaucoma was nominally associated with a decreased risk of Alzheimer's disease (OR = 0.96, 95% CI: 0.93-0.99, P = 0.013).”

    Humansgenetically predicted all-cause glaucoma

    Causal association among glaucoma, cerebral cortical structures, and Alzheimer's disease: insights from genetic correlation and Mendelian randomization

    Cerebral cortex (New York, N.Y. : 1991)

  4. Glaucoma is linked with a higher risk of Alzheimer's disease in humans (adjusted for sociodemographic factors and comorbidities) (adjusted HR 1.39 (95% CI 1.35-1.43)).

    “Persons with glaucoma had increased risks for AD (adjusted HR, 1.39; 95% confidence interval [CI], 1.35-1.43), VaD (1.66; 1.61-1.72), and all-cause dementia (1.57; 1.54-1.59).”

    Humansadjusted for sociodemographic factors and comorbidities

    Risk of Alzheimer's Disease and Related Dementias in Persons with Glaucoma: A National Cohort Study

    Ophthalmology

  5. Glaucoma is linked with a higher risk of Alzheimer's disease in humans.

    “Newly diagnosed glaucoma was associated with higher risk of AD but not VD.”

    Humans

    Risk of Dementia in Newly Diagnosed Glaucoma: A Nationwide Cohort Study in Korea

    Ophthalmology

  6. Glaucoma is associated with Alzheimer's disease in humans (HR 1.29, 95% CI 1.05–1.59).

    “the current meta-analysis indicates that that glaucoma patients have a higher AD risk.”

    Reviewn = 131,987

    Association between glaucoma and the risk of Alzheimer's disease: A meta-analysis

    Medicine

More on Alzheimer's disease

Diabetes mellitus

upin humans6OR 1.37

6 studies
  1. Diabetes mellitus is associated with glaucoma in humans (longitudinal study) (beta coefficient: 0.049, 95% CI: 0.028, 0.032, p<0.001).

    “had higher prevalence of diabetes (beta coefficient: 0.049, 95% CI: 0.028, 0.032, p<0.001)”

    Humanslongitudinal studyn = 9,973

    Incidence and risk factors for glaucoma and its clinical, mental health and economic impact in an elderly population: a longitudinal study

    BMJ open

  2. Diabetes mellitus is associated with glaucoma in humans (retrospective hospital cohort).

    “with a higher incidence among patients with DM and HTN”

    Humansretrospective hospital cohort

    Prediction of the Cause of Glaucoma Disease Identified by Glaucoma Optical Coherence Tomography Test in Relation to Diabetes and Hypertension at a National Hospital in Seoul: A Retrospective Study

    Diagnostics (Basel, Switzerland)

  3. Diabetes mellitus is linked with a higher risk of glaucoma in humans (AOR 1.554, p < 0.01).

    “the likelihood of cataract (AOR 1.495; p-value < 0.01) and glaucoma (AOR 1.554; p-value < 0.01) is significantly higher among older adults with diabetes than among their counterparts.”

    Humans

    Risk of cataract and glaucoma among older persons with diabetes in India: a cross-sectional study based on LASI, Wave-1

    Scientific reports

  4. Diabetes mellitus is linked with a higher risk of glaucoma in humans (p<0.05).

    “Diabetes, hypertension, and kidney disease were also associated with higher glaucoma risk”

    Humans

    The association between obesity and glaucoma in older adults: evidence from the China Health and Retirement Longitudinal Study

    Epidemiology and health

  5. Diabetes mellitus is associated with glaucoma in humans (older adults) (OR 1.37 (1.18-1.61) p < .001).

    “Glaucoma was independently associated with diabetes OR 1.37 (1.18-1.61) p < .001”

    Humansolder adults

    Self-reported glaucoma prevalence and related factors, contribution to reported visual impairment, and functional burden in a cross-sectional study in Colombia

    International ophthalmology

  6. Diabetes mellitus is linked with a higher risk of glaucoma in humans (new onset diabetes in postmenopausal women) (HR 1.151, 95% CI 1.086-1.220).

    “1.151 (95% CI, 1.086-1.220) in the new onset diabetes group”

    Humansnew onset diabetes in postmenopausal women2005 through 2018females

    Association between diabetes status and subsequent onset of glaucoma in postmenopausal women

    Scientific reports

More on Diabetes mellitus

GLP-1 receptor agonists

downin humans3downin reviews2HR 0.66

5 studies
  1. GLP-1 receptor agonists are linked with a lower risk of glaucoma in humans (HR 0.66, 95% CI 0.58–0.76).

    “GLP-1 RAs were associated with a reduced risk of glaucoma (HR 0.66, 95% CI 0.58–0.76)”

    Humans

    Anti‐obesity medications and incident ocular outcomes: A systematic review and network meta‐analysis

    Open Research (University of Surrey)

  2. GLP-1 receptor agonists lower the risk of glaucoma.

    “have been associated with reduced risk of age-related glaucoma”

    Review

    Geroprotective Agents, Including Glucagon-Like Peptide-1 Receptor Agonists, for Ocular Health

    Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics

  3. GLP-1 receptor agonists lower the risk of glaucoma in humans (diabetic and non-diabetic populations).

    “Complementary clinical and real-world evidence shows a robust and reproducible reduction in glaucoma risk among GLP-1RA users across diabetic and non-diabetic populations.”

    Reviewdiabetic and non-diabetic populations

    Glucagon-like Peptide-1 Receptor Agonists and Ocular Disease: Mechanisms, Evidence and Therapeutic Perspectives

    International journal of molecular sciences

  4. GLP-1 receptor agonists lower the risk of glaucoma.

    “emerging data suggest both potential therapeutic benefits—such as reduced glaucoma risk”

    Review

    Geroprotective Agents and Ocular Outcomes: A Scoping Review With Emphasis on GLP-1 RAs and Glaucoma

    Preprint

  5. GLP-1 receptor agonists lower the risk of glaucoma in humans across observational and preclinical studies.

    “Most studies found a statistically significant association between GLP-1 RA use and reduced glaucoma risk”

    Reviewacross observational and preclinical studies

    Glaucoma Risk Reduction as a Secondary Benefit of Glucagon-like Peptide-1 Receptor Agonists: A Review of Emerging Evidence

    Journal of current glaucoma practice

More on GLP-1 receptor agonists

Fine particulate matter

upin humans5RR 1.12

5 studies
  1. Fine particulate matter is linked with a higher risk of glaucoma in humans.

    “Ambient PM10 and PM2.5 concentrations in the Q2 and Q3 quartiles were associated with a higher prevalence of glaucoma in the study population.”

    HumansQ2 and Q3 quartilesn = 33,147

    Ambient air pollution and glaucoma among middle-aged and older adults in China: Evidence from the China health and retirement longitudinal study

    Environmental pollution (Barking, Essex : 1987)

  2. Fine particulate matter is linked with a higher risk of glaucoma in humans (independent of PA).

    “PM2.5 was independent risk factor for depressive symptoms and glaucoma in participants with or without depressive symptoms.”

    Humansindependent of PA

    PM2.5 exposure modifies the association of physical activity with depressive symptoms and glaucoma in middle aged and elderly Chinese

    Scientific reports

  3. Fine particulate matter is associated with glaucoma in humans (National age-standardized prevalence rates worldwide in 2019) (Prevalence r = 0.65; DALY rate r = 0.62).

    “National prevalence rates of VI and three major ocular diseases correlate significantly with PM2.5 exposure levels, worldwide.”

    HumansNational age-standardized prevalence rates worldwide in 2019

    The Correlation of Global Burden of Vision Impairment and Ambient Atmospheric Fine Particulate Matter

    Journal of current ophthalmology

  4. Fine particulate matter is associated with glaucoma in humans (OR = 1.14; 95% CI, 1.01-1.29).

    “glaucoma (OR = 1.14; 95% CI, 1.01-1.29)”

    Humans

    Fine Particulate Matter and Age-Related Eye Disease: The Canadian Longitudinal Study on Aging

    Investigative ophthalmology & visual science

  5. Fine particulate matter raises the risk of glaucoma in humans (long-term exposure) (pooled RR = 1.12; 95% CI, 1.06-1.18).

    “Higher long-term PM2.5 exposure was associated with an increased risk of glaucoma (pooled RR = 1.12; 95% CI, 1.06-1.18)”

    Reviewlong-term exposure

    Ambient Air Pollution and Glaucoma: A Systematic Review and Meta-analysis of Observational Studies

    Journal of current glaucoma practice

More on Fine particulate matter

Metformin

no changein humans2downin humans2OR 0.96

3 studies
  1. Metformin is associated with glaucoma in humans (newly diagnosed type 2 diabetes mellitus) (adjusted HR 1.076, 95% CI 0.995-1.163, p=0.067).

    “metformin monotherapy (N=100,387) showed a non-significant trend toward higher glaucoma diagnosis rates compared to matched controls (HR 1.106, 95% CI 1.014-1.207, p=0.023; adjusted HR 1.076, 95% CI 0.995-1.163, p=0.067).”

    Humansnewly diagnosed type 2 diabetes mellitusn = 100,387

    Glaucoma Risk with Metformin and Sulfonylurea Therapies in Type 2 Diabetes: A Retrospective Cohort Study

    Clinical ophthalmology (Auckland, N.Z.)

  2. Metformin is linked with a lower risk of glaucoma in humans (individuals of European ancestry with diabetes) (HR 0.81, 95% CI 0.67-0.97).

    “Metformin use was associated with a 19% lower glaucoma risk (hazard ratio, 0.81; 95% confidence interval [CI], 0.67-0.97; P = 0.019) in individuals of European ancestry”

    Humansindividuals of European ancestry with diabetes12.1 ± 2.8 yearsn = 24,206

    Protective Role of Metformin in Glaucoma: Prospective Cohort Study, Meta-Analysis, and Drug-Target Mendelian Randomization

    Ophthalmology science

  3. Metformin lowers the risk of glaucoma in humans (time-to-event analysis, adjusted models) (aHR = 0.88; 95% CI, 0.80-0.96).

    “persisted in adjusted models (aHR = 0.88; 95% CI, 0.80-0.96; I2 = 0.01%; moderate certainty).”

    Reviewtime-to-event analysis, adjusted models

    Metformin Use and Risk of Glaucoma: A Systematic Review and Meta-Analysis

    American journal of ophthalmology

  4. Metformin is associated with glaucoma in humans (crude binary analysis) (OR = 0.96; 95% CI, 0.87-1.06).

    “The pooled crude OR showed no association between metformin use and glaucoma risk (OR = 0.96; 95% CI, 0.87-1.06; I2 = 79.14%; low certainty).”

    Reviewcrude binary analysis

    Metformin Use and Risk of Glaucoma: A Systematic Review and Meta-Analysis

    American journal of ophthalmology

More on Metformin

Particulate matter

upin humans3+8% increaseHR 1.31

3 studies
  1. Particulate matter is linked with a higher risk of glaucoma in humans (nonmyopic) (8% increase).

    “PM2.5 was linked to an 8% increase in glaucoma incidence in the nonmyopic population.”

    Humansnonmyopicn = 114,930

    Associations Between Ambient Air Pollution and Five Common Vision-Threatening Ocular Diseases in Middle-Aged and Older Adults: A Large Prospective Cohort Study

    American journal of ophthalmology

  2. Particulate matter is associated with glaucoma in humans.

    “Individual exposure to PM2.5 mass and its five components was positively associated with glaucoma risk, respectively.”

    Humans

    Elevated serum uric acid levels mediate the associations of ambient PM2.5 and its components with glaucoma

    Chemosphere

  3. Particulate matter is linked with a higher risk of glaucoma in humans (HR 1.31, 95% CI 1.18-1.45).

    “The mixture of PM2.5 components were significantly and positively associated with glaucoma risk (hazard ratio [HR] = 1.31, 95% confidence interval [CI]: 1.18-1.45)”

    Humans

    Elevated serum uric acid levels mediate the associations of ambient PM2.5 and its components with glaucoma

    Chemosphere

  4. Particulate matter is associated with glaucoma in humans (pooled OR 1.18 (95% CI, 0.95-1.47)).

    “The pooled OR for each 10-μg/m3 increase of PM2.5 on glaucoma was 1.18 (95% CI, 0.95-1.47).”

    Revieweach 10-μg/m3 increase

    Ambient Air Pollution and Age-Related Eye Disease: A Systematic Review and Meta-Analysis

    Investigative ophthalmology & visual science

More on Particulate matter

Intraocular pressure

upin humans3HR 1.158

3 studies
  1. Intraocular pressure is linked with a higher risk of glaucoma in humans (HR 1.158, 95% CI 1.117-1.199).

    “higher intraocular pressure (per 1-mmHg increase; HR, 1.158; 95% CI, 1.117-1.199)”

    Humans13.0 ± 2.0 years

    Incidence and Risk Factors of Glaucoma in a Health Screening Cohort: Findings Over 10 Years from the Gangnam Eye Cohort Study

    American journal of ophthalmology

  2. Intraocular pressure is linked with a higher risk of glaucoma in humans.

    “Older age, higher IOP, lower alcohol intake, and higher C-reactive protein (CRP) levels were the significant risk factors for developing glaucoma.”

    Humans8 yearsn = 9,333

    Association between systemic conditions and the development of glaucoma in a longitudinal large-scale health examination cohort

    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie

  3. Intraocular pressure is linked with a higher risk of glaucoma in humans (two-sample Mendelian randomization).

    “We discovered IOP, AS, T2D as glaucoma risk factors”

    Humanstwo-sample Mendelian randomization

    Associations of human blood metabolome with optic neurodegenerative diseases: a bi-directionally systematic mendelian randomization study

    Lipids in health and disease

More on Intraocular pressure

Type 2 diabetes

upin humans2mixedin humans1HR 1.76

3 studies
  1. Type 2 diabetes is associated with glaucoma in humans (suggestive genetic correlation in individuals of European ancestry).

    “The LDSC analysis also indicated a suggestive genetic correlation between T2D and both cataracts and glaucoma, but not for T1D.”

    Humanssuggestive genetic correlation in individuals of European ancestry

    Genetic Correlation and Mendelian Randomization Analyses Reveal Causal Links Between Metabolic-Associated Diseases or Risk Factors and Major Eye Diseases

    Current eye research

  2. Type 2 diabetes is linked with a higher risk of glaucoma in humans (T2D diagnosed < 45 years vs controls) (HR 1.76, 95% CI 1.00-3.12).

    “T2D diagnosed < 45 years of age only was associated with an increased risk of glaucoma [HR (95%CI): 1.76 (1.00-3.12)].”

    HumansT2D diagnosed < 45 years vs controls

    Association of age at diagnosis of diabetes with subsequent risk of age-related ocular diseases and vision acuity

    World journal of diabetes

  3. Type 2 diabetes is linked with a higher risk of glaucoma in humans (OR 1.08, 95% CI 1.02–1.13).

    “"Glaucoma" (OR= 1.08; 95% CI: 1.02, 1.13; P=4.81×10−3)”

    Humans

    Dissecting causal associations of type 2 diabetes with 111 types of ocular conditions: a Mendelian randomization study

    Frontiers in endocrinology

More on Type 2 diabetes

Hypertension

upin humans3OR 1.26

3 studies
  1. Hypertension is associated with glaucoma in humans (longitudinal study) (beta coefficient: 0.019, 95% CI: 0.006, 0.008, p<0.001).

    “hypertension (beta coefficient: 0.019, 95% CI: 0.006, 0.008, p<0.001)”

    Humanslongitudinal studyn = 9,973

    Incidence and risk factors for glaucoma and its clinical, mental health and economic impact in an elderly population: a longitudinal study

    BMJ open

  2. Hypertension is associated with glaucoma in humans (retrospective hospital cohort).

    “with a higher incidence among patients with DM and HTN”

    Humansretrospective hospital cohort

    Prediction of the Cause of Glaucoma Disease Identified by Glaucoma Optical Coherence Tomography Test in Relation to Diabetes and Hypertension at a National Hospital in Seoul: A Retrospective Study

    Diagnostics (Basel, Switzerland)

  3. Hypertension is associated with glaucoma in humans (older adults) (OR 1.26 (1.08-1.46) p = .003).

    “hypertension 1.26 (1.08-1.46) p = .003”

    Humansolder adults

    Self-reported glaucoma prevalence and related factors, contribution to reported visual impairment, and functional burden in a cross-sectional study in Colombia

    International ophthalmology

More on Hypertension

Frailty

upin humans3OR 1.83–3.41

3 studies
  1. Glaucoma is associated with frailty in humans (compared to glaucoma suspects) (aOR 1.36, 95% CI 1.16–1.60).

    “Glaucoma patients were significantly more likely to be frail compared to glaucoma suspects (adjusted odds ratio=1.36, 95 % CI(1.16, 1.60)).”

    Humanscompared to glaucoma suspects

    The relationship between glaucoma and an electronic frailty index with the cumulative incidence of healthcare encounters for falls and fractures in older adults

    The Journal of frailty & aging

  2. Frailty is linked with a higher risk of glaucoma in humans (frail individuals vs nonfrail) (OR 1.83, 95% CI 1.05-3.19).

    “higher frailty levels were significantly associated with glaucoma in frail individuals (odds ratio [OR] = 1.83, 95% confidence interval [CI] = 1.05-3.19, P = 0.036)”

    Humansfrail individuals vs nonfrail

    Relationships between Frailty and the Risk of Glaucoma in Middle-aged and Older Adults

    Ophthalmology. Glaucoma

  3. Glaucoma predicts frailty in humans (longitudinal multivariable-adjusted) (OR 3.41 (95% CI 1.46 to 7.99)).

    “In the longitudinal analysis, the multivariable-adjusted OR (95% CI) for incident frailty associated with glaucoma, distance vision impairment, near vision impairment and vision problem was 3.41 (1.46 to 7.99)”

    Humanslongitudinal multivariable-adjusted

    Associations of vision impairment and eye diseases with frailty in community-dwelling older adults: a nationwide longitudinal study in China

    The British journal of ophthalmology

Medios-ai

upin humans1

1 study
  1. Medios-ai predicts glaucoma in humans (glaucoma screening) (AUROC 0.99, sensitivity 98.2%, specificity 99.0%).

    “For glaucoma (n = 109), sensitivity was 98.2% (95% CI: 94-100), specificity 99.0% (95% CI: 97-100), AUROC 0.99.”

    Human trialglaucoma screeningn = 109

    Smartphone-based offline AI for multi-disease retinal screening: Real-world accuracy

    European journal of ophthalmology

More on Medios-ai

Abnormal retinal image

upin humans1OR 3.749

1 study
  1. Glaucoma raises the risk of abnormal retinal image in humans (multivariate logistic regression) (OR = 3.749, 95% CI = 1.741-8.074, p = 0.0001).

    “Individuals who self-identified as having preexisting glaucoma (odds ratio [OR] = 3.749, 95% confidence interval [CI] = 1.741-8.074, p = 0.0001)”

    Human trialmultivariate logistic regression

    Manhattan Vision Screening and Follow-Up Study: (NYC-SIGHT)Tele-Retinal Image Findings and Importance of Photography

    Telemedicine journal and e-health : the official journal of the American Telemedicine Association

All 180

Trial sponsors

Funding

73 grants since 2016

National Eye Institute$63.4MNational Center for Chronic Disease Prev and Health Promo$6.9MUS Department of Veterans Affairs

How this record changed

  1. Summary rewritten as its findings changed.

    As it read before

    Human studies associate glaucoma with frailty and biological age acceleration; a cohort links it to later Alzheimer's disease and vascular dementia. A longitudinal study reports more falls, while a comparison with glaucoma suspects reports no difference in falls or fractures. A mouse study links glaucoma to retinal cellular senescence.

  2. Summary rewritten as its findings changed.

    As it read before

    In human studies, glaucoma is linked to retinal arteriosclerosis. Exposure to perfluorooctane sulfonic acid raises glaucoma risk, and perfluorodecanoic acid is associated with the disease in males.

  3. Summary written from the findings.

Latest

Dec 2025: 35Jan 2026: 45Feb 2026: 34Mar 2026: 45Apr 2026: 20May 2026: 21Jun 2026: 22Jul 2026: 35Aug 2026: 29Sep 2026: 33Oct 2026: 34Nov 2026: 16369 papers in 12 months
Canadian Journal of Ophthalmology Journal Canadien D'ophtalmologie

Ontario eye exam delisting linked to undetected eye disease

An estimated 260,273 Ontarians aged 40–64 likely had undetected chronic eye conditions between 2005 and 2021, after routine eye examinations lost coverage.An estimated 260,273 Ontarians aged 40–64 likely had undetected chronic eye conditions between 2005 and 2021, after routine eye examinations lost coverage.

Cohort studyIndustry & policy

See all 1,064 papers on glaucoma